Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Letermovir Use in Heart Transplant Recipients [Phase 4]
Phase 4 clinical trial evaluating Letermovir use in heart transplant recipients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients [NA]
This clinical trial update notes the completion of a multicenter prospective study examining cytomegalovirus resistance in transplant and bo…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant [NA]
This clinical trial update indicates the study completed screening healthy volunteers for cytomegalovirus in stool samples intended for feca…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) [Phase 3]
Phase 3 clinical trial evaluating safety, tolerability, pharmacokinetics, and antiviral activity of maribavir for cytomegalovirus infection …
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) [Phase 1]
This is a Phase 1 trial update reporting completion of a study evaluating allogeneic multivirus-directed cytotoxic T lymphocytes for Epstein…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients [Phase 4]
Phase 4 clinical trial evaluating CytoGam for cytomegalovirus infection or disease in solid organ transplant recipients. Enrollment is by in…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
This completed clinical trial update reports on the clinical and immunological features of cytomegalovirus infection with an atypical course…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045) [Phase 3]
This clinical trial update reports results from a Phase 3 study of letermovir (MK-8228) for preventing cytomegalovirus infection in Chinese …
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® [Phase 2]
Phase 2 study evaluating the safety and feasibility of infusing donor-derived virus-specific T cells for post-transplant viral infections in…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Dried Blood Spot Testing of CMV Detection in HCT Recipients [NA]
A completed clinical trial evaluated dried blood spot testing for cytomegalovirus detection in hematopoietic cell transplant recipients, wit…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes. [Phase 2]
A Phase 2 study evaluating the anti-inflammatory effects of Letermovir (Prevymis) in adults with HIV infection and asymptomatic cytomegalovi…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China
Single-center data from China on using letermovir prophylaxis to prevent cytomegalovirus infection in haploidentical hematopoietic stem cell…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT
Prospective survey evaluating CMV and other herpesvirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus,…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection [Phase 2]
Phase 2 trial evaluating prevention of cytomegalovirus infection in kidney transplant recipients using T gamma delta-CD16+ cells in combinat…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients
This clinical trial update reports the completion of a study evaluating the Viracor CMV assay to guide valganciclovir prophylaxis in high-ri…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: HCMV Breakthrough Infections During Letermovir Prophylaxis [NA]
Clinical trial update reporting breakthrough cytomegalovirus infections occurring despite letermovir prophylaxis in hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells [Phase 1]
The update describes a Phase 1 trial evaluating viral-specific T cell therapy for cytomegalovirus infections, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating third-party donor-derived CMVpp65-specific T cells for cytomegalovirus infection or persistent CMV viremia after al…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients [Phase 1]
Phase 1 study evaluating the safety, tolerability, and immunogenicity of the CMV vaccine ASP0113 in CMV-seropositive and CMV-seronegative he…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Study of CMV in Kidney Transplant Recipients
A terminated clinical trial studied cytomegalovirus viral loads in seropositive kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection [Phase 3]
Phase 3 trial in Japanese patients with cytomegalovirus infection has completed and posted results for maribavir.
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Cytomegalovirus Shedding Characteristics in Pregnant Women
The document notes that a clinical trial studying cytomegalovirus shedding in pregnant women has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reports termination of a Phase 2/Phase 3 study of posoleucel (ALVR105, Viralym-M) for multi-virus prevention in patien…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada
A completed clinical trial evaluating Cytomegalovirus infection outcomes among solid organ transplant recipients in Europe and Canada. The s…